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Background: Duplications of the chromosome 15q11-q13.1 region are associated with an estimated 1 to 3% of all
autism cases, making this copy number variation (CNV) one of the most frequent chromosome abnormalities
associated with autism spectrum disorder (ASD). Several genes located within the 15q11-q13.1 duplication region
including ubiquitin protein ligase E3A (UBE3A), the gene disrupted in Angelman syndrome (AS), are involved in
neural function and may play important roles in the neurobehavioral phenotypes associated with chromosome
15q11-q13.1 duplication (Dup15q) syndrome.
Methods: We have generated induced pluripotent stem cell (iPSC) lines from five different individuals containing
CNVs of 15q11-q13.1. The iPSC lines were differentiated into mature, functional neurons. Gene expression across the
15q11-q13.1 locus was compared among the five iPSC lines and corresponding iPSC-derived neurons using
quantitative reverse transcription PCR (qRT-PCR). Genome-wide gene expression was compared between neurons
derived from three iPSC lines using mRNA-Seq.
Results: Analysis of 15q11-q13.1 gene expression in neurons derived from Dup15q iPSCs reveals that gene copy
number does not consistently predict expression levels in cells with interstitial duplications of 15q11-q13.1.
mRNA-Seq experiments show that there is substantial overlap in the genes differentially expressed between
15q11-q13.1 deletion and duplication neurons, Finally, we demonstrate that UBE3A transcripts can be
pharmacologically rescued to normal levels in iPSC-derived neurons with a 15q11-q13.1 duplication.
Conclusions: Chromatin structure may influence gene expression across the 15q11-q13.1 region in neurons.
Genome-wide analyses suggest that common neuronal pathways may be disrupted in both the Angelman and
Dup15q syndromes. These data demonstrate that our disease-specific stem cell models provide a new tool to
decipher the underlying cellular and genetic disease mechanisms of ASD and may also offer a pathway to novel
therapeutic intervention in Dup15q syndrome.
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One of the most frequent chromosome anomalies asso-
ciated with autism is the duplication of chromosome
15q11-q13.1 [1-8]. The parent-of-origin is an important
factor for chromosome 15q11-q13.1 duplication (Dup15q)
syndrome because the chromosome 15q11-q13.1 region is
subject to genomic imprinting, which is an epigenetic
process that results in monoallelic gene expression. The
15q11-q13.1 duplications that lead to autism are most fre-
quently of maternal origin. In addition to autism, individ-
uals with maternally-inherited or derived duplications of
chromosome 15q11-q13.1 have hypotonia, developmental
delay, speech and language delay, behavioral difficulties,
and seizures. There are two major classes of chromosomal
duplication. First, interstitial duplications (int dup(15))
result in tandem copies of maternal 15q11-q13.1 lying
in a head-to-head orientation on the same chromosome
arm. Second, isodicentric chromosome 15 (idic(15)) du-
plications result in two additional copies of maternal
15q11-q13.1 which are flanked by two centromeres on a
supernumerary chromosome. Not surprisingly, individ-
uals with idic(15), who have 4 copies of 15q11-q13.1,
are more severely affected than those with int dup(15),
who have 3 copies [9].
Deletion of the maternal allele of chromosome 15q11-
q13.1 results in Angelman syndrome (AS) a neurodeve-
lopmental disorder characterized by developmental delay,
absent speech and seizures [10]. Deletion or loss of func-
tion of a single maternally expressed gene within 15q11-
q13.1, encoding ubiquitin protein ligase E3A (UBE3A),
is sufficient to cause AS [11-13]. Several studies sug-
gest that maternal duplication of UBE3A underlies the
autism phenotype associated with 15q11-q13.1 dupli-
cations [1,2,8,14]. However, the duplicated region also
includes several other genes, including a cluster of genes
encoding gamma aminobutyric acid (GABA) receptor sub-
units, GABRB3, GABRG3, and GABRA5. Additionally, all
idic(15) duplications and some int dup(15) duplications
include cytoplasmic FMRP interacting protein (CYFIP1),
which binds to and antagonizes the fragile X mental re-
tardation protein (FMRP) [15], the protein whose loss of
function causes Fragile X syndrome; and nonimprinted in
Prader-Willi/ Angelman syndrome region 1 and 2 (NIPA1
and NIPA2), genes encoding putative magnesium trans-
porters involved in seizures, schizophrenia, and hereditary
spastic paraplegia [16,17]. Therefore, non-imprinted genes
in the 15q critical duplication locus may play an important
role in the phenotype of individuals with both int dup (15)
and idic(15).
Here we report the generation of induced pluripotent
stem cell (iPSC) lines and neurons from individuals
with both isodicentric and interstitial duplications of
chromosome 15q11-q13.1. We compared gene expres-
sion between iPSCs and iPSC-derived neurons withboth deletions and duplications of this region. We
found that while the overall gene expression levels of
the chromosome 15q genes largely reflect the copy
number in AS and idic(15) iPSCs and neurons, the
gene expression levels did not correlate as well with
copy number in the paternal or maternal int dup(15)
neurons, suggesting that the inverted duplication may
disrupt distal regulatory elements that act primarily in
neural tissue. We also compared global transcriptome
expression between AS and idic(15) neurons and found
that despite having opposite genetic anomalies (dele-
tion in AS and duplication in idic(15)), most of the
genes differentially expressed in both disorders were
changed in the same direction. In fact, both disorders
result in the downregulation of genes involved in neuron
development, including many autism candidate genes.
Together, these data suggest different patterns of neur-
onal gene regulation between int dup(15) and idic(15)
and similar neuronal pathways disrupted in deletions
and duplication of chromosome 15q11-q13.1.Methods
Patient samples, regulatory approvals, iPSC derivation,
and cell culture
Idic(15) fibroblasts (catalog ID: GM07992) were ob-
tained from the Coriell Institute for Medical Research
Cell Repository. Idic(15) umbilical cord blood cells were
donated by the patient’s family through the Dup15q
Alliance and were exempted from consideration as hu-
man subject research by the University of Connecticut
Health Center Institutional Review Board (IRB). Fibro-
blasts from an individual with inherited paternal inter-
stitial 15q11-q13.1 duplication (patient 801-015) and an
individual mosaic for maternal interstitial 15q11-q13.1
duplication (mother of patient 801-018) were obtained
by Dr. Lawrence T. Reiter under IRB approval number
11-01350-FB from the University of Tennessee Health
Science Center. All patient samples were obtained from
subjects after they had given informed consent and were
subsequently de-identified.
iPSCs were generated with Institutional Biosafety
Committee approval number IBC08-005 from the Uni-
versity of Connecticut Health Center by the University
of Connecticut - Wesleyan University Stem Cell Core as
previously reported [18]. iPSCs were maintained on ir-
radiated mouse embryonic fibroblasts (MEFs) in human
embryonic stem cell medium which consists of DMEM/
F12, 20% knockout serum replacement, 1 mM L-glutamine,
1X nonessential amino acids, 100 mM β-mercaptoethanol
(all Gibco products through Life Technologies, Grand
Island, NY, USA), and 4 ng/mL basic fibroblast growth
factor (bFGF, Millipore, Billerica, MA, USA). iPSCs
were manually passaged every 6 or 7 days.
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hybridization, and whole genome copy number variation
analysis
Cytogenetic analysis of Dup15q iPSCs was performed by
the Genetics and Genomics Division of the University of
Connecticut - Wesleyan University Stem Cell Core.
Twenty G-banded metaphase cells from each iPSC line
were examined to generate a karyotype for each line.
DNA fluorescence in situ hybridization (FISH) was per-
formed on both metaphase and interphase cells using a
dual-labeled probe containing the small nuclear ribonu-
cleoprotein polypeptide N (SNRPN) gene and a control
locus at 15qter (Cytocell Aquarius LPU005-A-034359,
Cytocell, Cambridge, UK). Whole genome copy number
analysis was performed on genomic DNA isolated from
AS del 1-0 and Idic1-8 iPSCs using the Affymetrix
CytoScan HD Array (Affymetrix, Santa Clara, CA, USA)
to determine deletion/duplication breakpoints. Duplica-
tion breakpoints for the maternal and paternal Int dup
(15) patient samples were previously published (as patients
801-018 and 801-015, respectively) [8] and for IdicCB
were provided in an array CGH report accompanying the
patient sample.
Neural differentiation
iPSC-derived neural progenitors were generated by either
embryoid body (EB)-based or monolayer differentiation
according to established protocols [19,20] with minor
modifications. For EB differentiation, iPSC colonies were
manually detached from MEF feeders and put into sus-
pension culture rather than enzymatic dissociation. After
three weeks of neural differentiation (in both protocols),
neural progenitors were plated on poly-ornithine/laminin
coated substrates in neural differentiation medium con-
sisting of Neurobasal Medium, B-27 supplement, nones-
sential amino acids, and L-glutamine (all Gibco products
through Life Technologies, Grand Island, NY, USA)
supplemented with 1 μM ascorbic acid, 200 μM cyclic
adenosine monophosphate (cAMP), 10 ng/mL brain-
derived neurotrophic factor (BDNF, Peprotech, Rocky
Hill, NJ, USA), and 10 ng/mL glial-derived neurotrophic
factor (GDNF, Peprotech, Rocky Hill, NJ, USA). All
experiments were conducted on neural cultures that
were at least 10 weeks old.
For mithramycin experiments, mithramycin A (Sigma-
Aldrich, St. Louis, MO, USA) was prepared as a 1 mM
concentrated stock in dimethyl sulfoxide (DMSO, Sigma-
Aldrich, St. Louis, MO, USA). Working stocks were di-
luted in DMSO and added to neural differentiation
medium immediately before addition to neural cultures.
Immunocytochemistry
Immunocytochemistry was performed as previously de-
scribed [18] on iPSCs or 10-week old iPSC-derivedneurons that had been cultured on glass coverslips. The
following antibodies and concentrations were used:
mouse anti-Tra-1-60 (1:200, Santa Cruz Biotechnology,
Inc, Dallas, TX, USA), Nanog (1:200, Abcam, Cambridge,
UK), mouse anti-SSEA-4 (1:20, Developmental Studies
Hybridoma Bank, Iowa City, IA, USA), chicken anti-
MAP2 (1:10,000, Abcam, Cambridge, UK), rabbit anti-
MAP2 (1:500, Millipore, Billerica, MA, USA), rabbit
anti-Synapsin I (1:400, Millipore, Billerica, MA, USA),
mouse anti-PSD-95 (1:100, NeuroMab, Davis, CA, USA),
rabbit anti-S100β (1:200, Abcam, Cambridge, UK), mouse
anti-VGlut1 (1:100, Synaptic Systems, Gottingen, Germany),
and rabbit anti-Gad65 (1:500, Sigma-Aldrich, St. Loius,
MO, USA). All AlexaFluor fluorochrome conjugated
(488, 594, and 647) secondary antibodies (Life Tech-
nologies, Grand Island, NY, USA) were used at 1:400.
A goat anti-chicken IgY-650 secondary antibody (Abcam,
Cambridge, UK) was used at 1:250. Nuclei were counter-
stained with DAPI and coverslips were mounted on slides
with Vectashield (Vector Laboratories, Burlingame, CA,
USA). Slides were imaged using a Zeiss Axiovision
microscope (Carl Zeiss, Germany) at 20X, 40X, and 63X
magnification.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed
according to the EZ-Magna ChIP protocol (Millipore,
Billerica, MA, USA) according to manufacturer’s instruc-
tions with minor modifications. DMSO or mithramycin-
treated 10-week old idic(15) neurons were treated with
1% formaldehyde to crosslink DNA/protein. Instead of a
two-step cell lysis, cells were lysed once for 15 minutes
in an SDS Cell Lysis Buffer (Millipore, Billerica, MA,
USA) before sonication. A rabbit polyclonal anti-YY-1
(sc-281, Santa Cruz Biotechnology, Inc, Dallas, TX, USA)
was used at 5 μg per immunoprecipitation reaction. For
ChIP analysis of Sp1 binding, the following antibodies
were used: mouse monoclonal anti-Sp1 (sc-17824, Santa
Cruz Biotechnology, Inc, Dallas, TX, USA) and anti-Sp1
(#9389, Cell Signaling Technology, Beverly, MA, USA).
Novex Protein A DynaBeads magnetic beads (Life Tech-
nologies, Grand Island, NY, USA) were used during
immunoprecipitation. Immunoprecipitated DNA was
purified by phenol-chloroform extraction and used for
quantitative polymerase chain reaction (qPCR) with
SYBR-Green reagents (Life Technologies, Grand Island,
NY, USA). The following primers were used for qPCR:
UBE3A-exon1 forward GGC AGA GGT GAA GCG
TAA GT, UBE3A-exon1 reverse AGA TCC GTG TGT
CTC CCA AG, UBE3A-upstream forward TCT GTG
ACC CGA AAG AAT AAA CC, UBE3A-upstream re-
verse TTC CTC TGC TGG GTA CAC CAA. Sp1 pro-
moter forward TGC CCG CCT GAT TTC TGA, Sp1
promoter reverse GGA TAT GCT TGG GCA AAA
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ATA GGG AC, DHFR promoter reverse AGA ACG
CGC GGT CAA GTT TG. ChIP was performed with
triplicate independent batches of neurons. qPCR was
performed in triplicate for each DNA sample and Ct
values were used to calculate percent of input. Percent
of input values for YY-1 binding were normalized by
subtracting the background binding of normal rabbit
IgG (Millipore, Billerica, MA, USA). Fold enrichment was
then calculated by dividing percent input in mithramycin-
treated samples by percent input of DMSO-treated
controls.Quantitative reverse-transcription PCR
Total RNA was isolated from iPSCs, EBs, or iPSC-derived
neurons using RNA-Bee (AMS Biotechnology, Lake
Forest, CA, USA) according to the manufacturer’s proto-
col. cDNA was produced using the High Capacity cDNA
Reverse Transcription Kit (Life Technologies, Grand
Island, NY, USA).
Analysis of iPSC pluripotency genes was performed
on independent cultures of each iPSC line in triplicate
with a TaqMan Human Stem Cell Pluripotency Array
(Life Technologies, Grand Island, NY, USA). Analysis of
multipotency and neural differentiation capacity was
performed with a custom TaqMan Gene Signature Array
Card (Life Technologies, Grand Island, NY, USA) as previ-
ously described [21] on three independent batches of EBs
derived from each iPSC line. This custom array includes
representative genes from all three germ lineages as well
as pluripotency genes. A full list of gene assays included
in the custom array is available in Martins-Taylor et al.
[21]. Ct values for all genes were first normalized to 18S
rRNA and then set relative to the housekeeping gene
glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Analysis of 15q11-q13.1 genes and selected autism
candidate genes in iPSCs and iPSC-derived neurons was
performed in duplicate or triplicate from independent
cultures. All qPCR assays used were TaqMan Gene Expres-
sion Assays (Life Technologies, Grand Island, NY, USA). Ct
values for each gene were normalized to the house keeping
gene GAPDH. Relative expression was quantified as 2^-ΔΔCt
using normal (Nml 1-0) iPSCs or normal iPSC-derived
neurons as the calibrator sample.Methylation analysis
Analysis of methylation at the Prader-Willi syndrome
imprinting center (PWS-IC) was performed using the
Methyl-Profiler DNA Methylation qPCR Assay kit (SA
Biosciences, Valencia, CA, USA) and the EpiTect Methyl
qPCR Assay for SNRPN (Qiagen, Valencia, CA, USA) as
previously described [18].Allele-specific single nucleotide polymorphism analysis
The UCSC Genome Browser (http://genome.ucsc.edu/)
was used to identify a single nucleotide polymorphism
(SNP), rs691, which is located in the last exon of the
imprinted in Prader-Willi syndrome (IPW) gene. Genomic
DNA from mat. int dup(15), pat. int dup(15), and idic(15)
fibroblasts, and IdicCB-09 iPSCs was used to determine
heterozygosity for rs691 by PCR amplification across
the SNP followed by sequencing by GENEWIZ. Total
RNA was isolated from fibroblasts (mat. int dup(15) and
idic(15)), iPSCs, and iPSC-derived neurons (mat. int dup
(15)-02, pat. int dup(15)-04, Idic1-8, and IdicCB-09) using
RNA-Bee (AMS Biotechnology, Lake Forest, CA, USA)
and DNase treated using Turbo DNA-free Kit (Life Tech-
nologies, Grand Island, NY, USA). cDNA was generated
using the High Capacity cDNA Reverse Transcription Kit
(Life Technologies, Grand Island, NY, USA) and used for
PCR amplification across rs691 followed by sequencing by
GENEWIZ. The following primers were used to amplify
across rs691: forward ATG CCC TCC TCT CTT CCA
ATand reverse ATA GGG AGG TTC ATT GCA CA.
Electrophysiology
Individual coverslips were transferred to a recording
chamber (room temperature) fixed to the stage of an
Olympus BX51WI microscope (Olympus, Tokyo, Japan)
fitted with a 40x water-immersion lens. The recording
chamber was continuously perfused at 2 ml/min with
oxygenated artificial cerebrospinal fluid (125 mM NaCl,
2.5 mM KCl, 1.25 mM NaH2PO4, 1 mM MgCl2-6H2O,
25 mM NaHCO3, 2 mM CaCl2, and 25 mM dextrose).
Cells were selected for recording based on neuronal
morphology. Whole-cell voltage clamp (holding poten-
tial = -70 mV) and current clamp recordings were con-
ducted as previously described [18,22]. Series resistance
(Rs) was compensated to 70% or greater at 10 to 100 μs
lag. During the course of the experiments, input resistance
(Ri) was continuously monitored with 5 mV hyperpolariz-
ing voltage steps (50 ms). Neurons were rejected from
analyses if (1) Rs was >25 MOhms at the time of break-in,
if (2) Ri changed by >15% during the course of an experi-
ment, or if (3) Ri fell below 100 MOhms.
Transcriptome analysis
Total RNA was isolated from two biological replicates of
10-week-old neurons derived from AS (AS del 1- 0),
normal (Nml 1- 0), and idic(15) (Idic1-8) iPSCs. mRNA-
Seq libraries were prepared using 5 μg of total RNA ac-
cording to manufacturer’s specifications (Illumina, San
Diego, CA, USA) using the Paired-end Library kit as de-
scribed in [23]. Libraries were multiplexed and sequenced
on Illumina GAIIx and HiSeq 2000 sequencers (Illumina,
San Diego, CA, USA). The reads were aligned to the hu-
man genome (hg19) using Bowtie (version 0.12.0-beta1)
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mapped reads were generated for each sample. Cufflinks
(version 0.9.3) was used to quantitate expression levels
for all hg19 UCSC genes and transcripts as fragments
per kilobase gene model per million base pairs (FPKM)
[25]. All raw sequencing data has been deposited in the
National Center for Biotechnology Information (NCBI)
Sequence Read Archive (http://www.ncbi.nlm.nih.gov/sra)
under the accession number SRP044749.
Copy number analysis
The copy number of UBE3A in each iPSC line was ana-
lyzed by qPCR using genomic DNA purified from two
biological replicates and TaqMan Copy Number Assays
(Hs01665678_cn and Hs03908756_cn, Life Technologies,
Grand Island, NY, USA). The RNase P Copy Number
Reference Assay was used as an endogenous reference
gene to allow for quantification of UBE3A copy number.
Data were analyzed using the CopyCaller v2.0 software
from Applied Biosystems (Life Technologies, Grand
Island, NY, USA).
RNA FISH
iPSCs grown on glass coverslips were processed for
RNA-FISH as previously described [21] with the follow-
ing modifications: UBE3A BAC probe RP11-1081A4 was
labeled by nick translation and 500 ng of labeled probe
was used for hybridization.
Statistical analyses
Electrophysiology data for current-voltage relationship
and average frequency and amplitude of synaptic currents
are presented as the mean plus or minus the standard
error of the mean. All qPCR data were analyzed using
Microsoft Excel and are presented as the mean relative ex-
pression plus or minus the standard error of the mean.
Differential gene expression was analyzed for statistical
significance using either one-way ANOVA followed by
Tukey’s multiple comparisons test or an unpaired two-
tailed t-test. ChIP data are presented as the mean fold en-
richment plus or minus the standard error of the mean.
Differences in fold enrichment were analyzed for statistical
significance using an unpaired two-tailed t-test.
Results
Generation of iPSCs from Dup15q patients
iPSC lines were established using fibroblasts from one idic
(15) individual, one individual with a paternally-inherited
duplication of chromosome 15q11-q13.1, and one individ-
ual who was mosaic for a maternally-inherited interstitial
duplication of chromosome 15q11-q13.1 (Figure 1a).
iPSC lines were also established from a cord blood
sample from one individual with idic(15) (Figure 1a).
iPSCs were generated using either retroviral, lentiviral,or episomal vectors encoding POU class 5 homeobox 1
(OCT4), SRY-box 2 (SOX2), Kruppel-like factor 4
(KLF4), v-myc avian myelocytomatosis viral oncogene
homolog (MYC), and lin28 homolog A (LIN28) [see
Additional file 1: Table S1] [26-28]. Reprogrammed
colonies were initially identified morphologically, and
were subsequently validated using qRT-PCR and/or
immunocytochemistry to verify the expression of the
pluripotency markers, NANOG, stage specific embryonic
antigen 4 (SSEA4), and TRA1-60 (Figure 1b-d) and pluri-
potency genes [see Additional file 2: Figure S1A]. iPSCs
were shown to have the expected karyotypes of 46, XX
(normal); 46,XX.ish dup(15)(q11.2q11.2)(SNRPN++);
or 47,XX,+idic(15).ish15q12 SNRPN x 4, 15qter X2
(Figure 1e). Interstitial duplication of 15q11-q13.1 or
the presence of the isodicentric chromosome 15 was
confirmed in representative iPSC clones by DNA FISH
with a probe for the SNRPN gene and a control probe
in the distal long arm of chromosome 15 (Figure 1f and
Figure 1g). Breakpoints involved in the duplications in
the two int dup(15) samples were previously identified
by array comparative genomic hybridization (CGH)
[8]. Breakpoints in the cord blood idic(15) sample were
determined by genetic report obtained during diagno-
sis, and the breakpoints in the fibroblast idic(15) and
AS samples were determined using a high density SNP
array as part of the current study. Gene expression arrays
were used to analyze gene expression in iPSC-derived EBs
after 16 days of spontaneous differentiation as previously
described [18,21]. These data demonstrate that all iPSCs
used are capable of multi-lineage differentiation, since
early lineage markers representing each of the three em-
bryonic germ layers as well as the trophectoderm layer are
expressed [see Additional file 2: Figure S1B].
Dup15q iPSCs maintain the appropriate methylation
imprint following reprogramming
We previously demonstrated that the methylation im-
print at the PWS-IC was maintained during reprogram-
ming in AS, PWS and normal iPSCs [18]. We assessed
the methylation imprint at the PWS-IC in normal and
Dup15q iPSCs using methylation-specific qPCR [29,30].
We expected that iPSCs from idic(15) iPSCs would have
approximately 75% methylation due to the presence of 3
maternal and 1 paternal alleles. We expected that pater-
nal int dup(15) iPSCs would have approximately 33%
methylation resulting from one maternal and two pater-
nal alleles. We expected that some of the iPSCs from the
individual mosaic for a maternal int dup(15) would arise
from cells with the duplication and thus would have 66%
methylation resulting from 2 maternal and one paternal
alleles, while others would be derived from the normal
cells and have 50% methylation. Consistent with this
prediction, idic(15) iPSCs had methylation levels ranging
Figure 1 Characterization of chromosome 15q11-q13.1 duplication (Dup15q) induced pluripotent stem cell (iPSCs). (a) Map of the
15q11-q13.1 region. Boxes indicate genes (grey = biallelically expressed, red =maternally expressed, blue = paternally expressed) and lines indicate
small nucleolar RNAs (snoRNAs). The striped boxes for ATP10A signify its variable imprinting status. The UBE3A anti-sense transcript is represented
by the dotted line beginning at SNURF-SNRPN. Pink and blue shaded regions demarcate the Angelman Syndrome and Prader-Willi Syndrome
imprinting centers (AS-IC and PWS-IC), respectively. Open circles represent unmethylated CpG islands, while the corresponding black circles on
the maternal allele represent methylated CpG islands in silenced genes (black boxes). Breakpoints (BP1-BP5) are indicated. The regions deleted or
duplicated in iPSC lines used in this study as well as their respective maternal (M) or paternal (P) allele copy numbers are indicated below the
map. (b-d) Immunocytochemistry for the pluripotency markers TRA-1-60, Nanog, and SSEA-4 on idic(15) iPSC colonies (Idic1-8). Nuclei are
counterstained with DAPI (blue). (e) Karyogram of idic(15) iPSCs shows a karyotype of 47,XX,+idic(15).ish15q12 SNRPN x 4, 15qter X2. Red box
indicates the supernumerary isodicentric chromosome 15. (f, g) DNA FISH on metaphase idic(15) iPSCs (F) and interphase int dup(15) iPSCs (G)
with a probe for SNRPN (red) and a control probe on the distal long arm of chromosome 15 (green). Two normal chromosomes 15 are indicated
by white arrows (F). The isodicentric chromosome 15 (highlighted in white box and inset) shows four signals for SNRPN and no signal for the
control probe (F). Three signals for SNRPN and two control signals indicate the presence of the interstitial duplication of 15q11-q13.1 on one
chromosome 15 (G). Scale bars in (B) and (D) are 200 μm, in (C) is 100 μm, in (F) is 5 μm and in (G) is 10 μm.
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methylation levels ranging from 23% to 27% (Table 1,
Additional file 3: Table S2). Two iPSC lines from the
mosaic int dup(15) individual had methylation levels of
54% and 57% [see Additional file 3: Table S2]. One line
showed normal diploid cells by karyotype analysis (mat.
int dup(15)-12), while the other was a mixed culture,
having both duplication and normal cells (mat. int dup
(15)-18). The remaining iPSC clones from the mosaic
individual had methylation levels ranging from 65% to68% (Table 1). Thus, DNA methylation at the PWS-IC is
consistent with the predicted copy number variations of
the Dup15q cell lines and seems to be maintained during
reprogramming.
To further investigate the maintenance of parental im-
printing following reprogramming of patient cells into
iPSCs and differentiation of iPSCs into neurons, we per-
formed allele-specific RT-PCR for the paternally expressed
imprinted in Prader-Willi syndrome (IPW) gene. We first
identified a SNP (rs691) in the last exon of IPW and
Table 1 Methylation analysis of chromosome
15q11-q13.1 duplication syndrome (Dup15q) induced
pluripotent stem cells (iPSCs) at the Prader-Willi
syndrome imprinting center (PWS-IC)
Cell line % methylated at PWS-ICa
mat. Int dup(15) 66.57 ± 0.92
mat. Int dup(15)-02 66.15 ± 2.12
mat. Int dup(15)-12b 65.64 ± 3.25
pat. Int dup(15) 25.31 ± 1.46
pat. Int dup(15)-04 23.53 ± 2.93
Idic 76.94 ± 5.02
Idic1-8 72.43 ± 1.00
IdicCB 77.35 ± 3.52
IdicCB-07 79.49 ± 5.03
IdicCB-09 72.29 ± 9.69
aDNA methylation at the PWS-IC was assayed by methylation specific qPCR
using genomic DNA from Dup15q iPSCs. The average calculated percent
methylation from all clones within a genotype is presented plus or minus the
standard deviation in bold text. The averages calculated for percent methylation
from three replicate assays each for selected clones plus or minus the standard
deviation are shown in plain text. bThe mat. int dup(15)-12 cell line was originally
identified as an isogenic normal clone derived from the individual with maternal
interstitial duplication. However, methylation analysis after approximately 25
subsequent passages suggests that this clone was mosaic and resolved to
contain predominantly duplication containing cells. PWS-IC, Prader-Willi
syndrome imprinting center; mat. Int dup(15), maternal interstitial
duplication of 15q11-q13.1; pat. Int dup(15), paternal interstitial duplication
of 15q11-q13.1; Idic, isodicentric chromosome 15; IdicCB, isodicentric
chromosome 15 cord blood derived sample.
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mat. int dup(15), pat. int dup(15), and idic(15) patient
fibroblasts [see Additional file 4: Figure S2]. We were
unable to investigate the SNP in genomic DNA from
the umbilical cord blood idic(15) starting cell popula-
tion; however, we did confirm heterozygosity in gen-
omic DNA from the iPSCs derived from these cells. We
then generated cDNA from the patient fibroblasts, iPSCs,
and neural derivatives and, by sequencing across the SNP
in IPW, confirmed that IPW is expressed monoallelically
and from the same allele as in the patient cell sample [see
Additional file 4: Figure S2]. Together with the DNA
methylation pattern at the PWS-IC, this data suggests that
parental imprinting at the 15q11-q13.1 locus is maintained
following reprogramming to iPSCs.
Functional neurons derived from Dup15q iPSCs
To prioritize individual iPSC lines based on their ability
to differentiate into neurons, all clones of the Dup15q
iPSCs from each genotype were allowed to spontaneously
differentiate in EB culture and were subjected to qRT-PCR
using a custom PCR array containing a panel of neural
genes and pluripotency genes [21]. Expression levels of
all genes in the array were analyzed relative to those of
EBs derived from AS iPSCs, which we previously re-
ported to be capable of generating functional neurons[see Additional file 5: Figure S3A-D] [18]. Representa-
tive iPSC clones of each genotype were selected for fu-
ture experiments based on low levels of expression of
the pluripotency genes NANOG and zinc finger protein
42 (ZFP42) and expression levels of neural lineage genes,
such as paired box 6 (PAX6), microtubule associated
protein 2 (MAP2), and neural cell adhesion molecule 1
(NCAM1) that were similar to or higher than those of
AS iPSC-derived EBs.
The selected iPSC clones from each Dup15q genotype
were then differentiated using either an EB-based differ-
entiation protocol that mimics embryonic development
or a modified monolayer neural differentiation protocol
[19,20,31]. Both protocols generated neural progenitors
and subsequently post-mitotic neurons from all genotypes.
Analysis of 10-week-old monolayer neuronal cultures by
immunocytochemistry demonstrated the cultures largely
consisted of MAP2-positive neurons (Figure 2a). Astro-
cytes, labeled by S100 calcium binding protein beta
(S100β), were also observed (Figure 2b). The neuronal
population contained both vesicular glutamate trans-
porter 1 (VGlut1)-positive excitatory neurons and glu-
tamate decarboxylate 65 (GAD65)-positive inhibitory
neurons (Figure 2c and Figure 2d). Co-localization of
the postsynaptic density protein PSD-95 and the pre-
synaptic marker Synapsin I along MAP2-positive neur-
ites indicates the formation of functional synapses in
10-week-old neuronal cultures (Figure 2e-e”).
In order to compare neural cultures derived from the
different cell lines used in this study, with respect to the
types of cells present, we analyzed expression of neuronal
(βIII-tubulin, RNA binding protein fox-1 homolog 3
(RBFOX3), and T-box brain 1 (TBR1)) and glial (S100β)
genes in three independent neural cultures from each cell
line. This analysis revealed that there was no significant
difference in mean expression levels between cell lines
[see Additional file 6: Figure S4A] (one-way ANOVA; βIII-
tubulin: F6,14 = 0.9295, P = 0.5037; RBFOX3: F6,14 = 1.938,
P = 0.1443; TBR1: F6,14 = 2.174, P = 0.1086; and S100β:
F6,14 = 2.786, P = 0.0535). We also determined that all cell
lines yielded neural cultures expressing similar levels of
genes specific to excitatory (VGLUT2) and inhibitory
(GAD1) neurons (Additional file 6: Figure S4A, one-way
ANOVA; VGLUT2: F6,14 = 2.597, P = 0.0662 and GAD1:
F6,14 = 2.932, P = 0.0456). Though the levels of expres-
sion varied between cell lines, we observed that all cell
lines generated cells which expressed markers of dorsal
forebrain including forkhead box G1 (FOXG1), PAX6,
and orthdenticle homeobox 2 (OTX2) [see Additional
file 6: Figure S4A] (one-way ANOVA; FOXG1: F6,14 =
11.75, P < 0.0001; PAX6: F6,14 = 3.878, P = 0.0172; and
OTX2: F6,14 = 11.97, P < 0.0001). The midbrain specific
gene engrailed 1 (EN1) was expressed in neural cul-
tures from all cell lines but at noticeably lower levels
Figure 2 Characterization of neurons derived from chromosome 15q11-q13.1 duplication syndrome (Dup15q) induced pluripotent
stem cells (iPSCs). (a) Immunocytochemistry for the neuronal marker MAP2 (red) indicates the presence of mature neurons in 10-week-old
Idic1-8 iPSC-derived monolayer neuronal cultures. (b) S100β-positive astrocytes (red) are also present after 10 weeks of neural differentiation.
(c) VGlut1-positive (green) excitatory and (d) GAD-65-positive (red) inhibitory neurons show a mixed population of neurons. (e) MAP2-positive
(red) neurons are decorated with PSD-95 (green) and (e’) Synapsin (blue) puncta. (e”) Merged image showing co-localization of PSD-95 and
Synapsin suggests the formation of functional synapses. Nuclei are counterstained with DAPI (blue). All scale bars are 20 μm.
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Figure S4A] (one-way ANOVA, F6,14 = 7.664, P = 0.0009).
We also assayed for expression of NK2 homeobox 2
(NKX2.1), a marker of ventral forebrain progenitors,
and found that its levels were very low or undetectable
in most cultures. Importantly, the replicate neural cul-
tures used in these experiments included those derived
by both monolayer culture and EB differentiation, dem-
onstrating that there were no significant differences in
the types of cells generated between the two protocols.
Electrophysiological recordings of idic(15) iPSC-derived
neurons
We carried out electrophysiological recordings from
differentiated neurons derived from the idic(15) iPSC
line (Idic1-8) during in vitro development using the EB
differentiation protocol. In 3-week-old cultures, most
neurons (21/24 cells) fired a single mature action potential
in response to depolarizing current injection. In 6-week-
old cultures, trains of action potentials were induced in
more than half of the neurons recorded (29/51 cells).
At weeks 12 to 14, a similar percentage of cells fired
trains of mature action potentials and displayed large
(>1 nA) inward and outward currents in response to
depolarization (Figure 3a-c). Inward sodium currents
and action potentials were blocked by the sodium
channel blocker tetrodotoxin (1 μM; data not shown).
Spontaneous excitatory synaptic events were seen in about
half of the neurons in 6-week-old cultures (28/52 cells),with an average frequency of 0.11 ± 0.03 Hz (n = 28). In
14-week-old cultures, as shown in Figure 3d-e, isolated
synaptic currents and occasional bursts of activity were
seen in the majority of cells at a slightly higher frequency
(0.22 ± 0.05 Hz; n = 20). Spontaneous excitatory synaptic
currents were blocked by the AMPA receptor antagonist
6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) (10 μM;
data not shown). These data indicate that Dup15q neu-
rons show in vitro maturation of intrinsic excitability
and evidence of functional synapses, laying the ground-
work for a detailed comparison of functional properties
among different genotypes.
Expression of 15q11-q13.1 genes in Dup15q iPSCs and
iPSC-derived neurons
The 15q11-q13.1 region includes several genes involved
in neuronal structure and function (Figure 1a). Imprinting
in the 15q11-q13.1 region results in allele-specific ex-
pression of several genes such that in non-neuronal
cells (including pluripotent cells), SNRPN is expressed
from the paternal allele and UBE3A is expressed from
both parental alleles. In neurons, however, SNRPN is
still expressed solely from the paternal allele, but UBE3A
becomes paternally silenced and is expressed only from
the maternal allele [32]. While some studies suggest that
ATP10A is maternally expressed in the brain, others sug-
gest that it is biallelically expressed or that its imprinting
status varies among individuals [33]. Other genes in the
region, including TUBGCP5, CYFIP1, NIPA1, GABRB3,
Figure 3 Electrophysiological characterization of induced pluripotent stem cell (iPSC)-derived neurons from a chromosome
15q11-q13.1 duplication syndrome (Dup15q) subject. (a) Representative whole cell potassium currents (top) and sodium currents (bottom)
recorded from a 12-week-old Idic1-8 iPSC-derived neuron generated using the embryoid body based differentiation protocol. (b) Current-voltage
relationship for peak sustained K current (filled triangles) and peak Na current (open triangles) from 12-week-old neurons (n = 16). (c) Representative
action potential train from a 12-week-old neuron. (d) Example sweeps of excitatory synaptic currents recorded from a 14-week-old neuron. (e) Group
data showing average frequency and amplitude of synaptic currents in 14 week-old-neurons (n = 20).
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cell types tested to date. Evidence from analysis of both
Dup15q lymphoblast and postmortem brain tissue
samples suggests that expression levels of these genes
differ significantly from normal individuals [34,35]. To
investigate whether copy number variations of the
15q11-q13.1 region result in corresponding changes in
the expression of genes located in the region, we per-
formed qRT-PCR with iPSCs and iPSC-derived neurons
(both monolayer and EB-derived) from all genotypes for
TUBGCP5, CYFIP1, NIPA1, SNRPN, UBE3A, ATP10A,
GABRB3, HERC2, and CHRNA7 [see Additional file 7:
Figure S5A-B]. In each case, we compared the expression
level of the gene in the disease-specific cells to the normal
cells.
For all genotypes, expression of the 15q11-q13.1 genes
in iPSCs generally corresponded to expressed copy num-
ber when compared to iPSCs derived from a control in-
dividual (Nml 1-0) (Figure 4a, top panel). The levels of
expression of paternal-specific SNRPN in AS iPSCs and
in the maternal int dup (15) and idic(15) iPSCs weresimilar to normal iPSCs because they only have a single
active copy of the gene. The paternal int dup(15) iPSCs
showed a twofold increase in SNRPN expression com-
pared to normal iPSCs, reflecting the two active copies
of the gene (Figure 4a, top panel; Additional file 7:
Figure S5A). UBE3A, which is not imprinted in iPSCs
was expressed at approximately half the level of nor-
mal in AS iPSCs and between two- and threefold of
normal in idic(15) iPSCs. While UBE3A expression fell
within the range of normal expression in both iPSC
lines derived from the maternal int dup(15) sample
and the paternal int dup(15) iPSCs, the average UBE3A
expression level in all three of these iPSC lines was
consistently higher than that of normal iPSCs.
The expression levels of HERC2 and NIPA1 were not
as predicted from copy number in some of the iPSC
lines. HERC2 was expressed at levels near or slightly less
than those seen in normal iPSCs in both the paternal
and maternal int dup(15) iPSCs (Figure 4b, top panel;
Additional file 7: Figure S5A). Expression of NIPA1 was
roughly half that of normal iPSCs in both clones of the
ab
Figure 4 Expression of 15q11-q13.1 genes in chromosome 15q11-q13.1 duplication syndrome (Dup15q) induced pluripotent stem cells
(iPSCs) and iPSC-derived neurons. (a) Box plots depicting the distribution of average mRNA expression levels of 15q11-q13.1 genes in Dup15q
iPSCs (top) and 10-week-old iPSC-derived neurons (bottom) relative to normal samples (Nml 1-0) as they correspond to the number of expressed
copies of each gene. The dark gray line in the center of each box represents the median of the average relative mRNA expression levels of genes
containing each number of expressed gene copies. Boxes indicate the 25th, 50th, and 75th percentiles. Whiskers represent the 5th and 95th
percentiles. The data point for SNRPN in the pat. int dup(15)-04 iPSCs (marked by asterisk) is not indicative of unexpected mRNA expression levels
relative to gene copy number, since this paternally expressed gene is duplicated on the paternal allele in this sample. (b) The average mRNA
expression levels for selected 15q11-q13.1 genes in Dup15q iPSCs (top) and 10-week-old iPSC-derived neurons (bottom) relative to that of normal
(Nml 1-0) iPSCs and neurons is presented in relation to the respective number of expressed copies of each gene.
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Figure S5A].
Expression levels of most 15q11-q13.1 genes in 10-
week-old AS and idic(15) iPSC-derived neurons also
largely correlated with their respective expressed copy
numbers (Figure 4a, bottom panel), with one notable
exception. HERC2 expression in one of the idic(15) cell
lines (IdicCB-09) was nearly 4.5-fold higher than normal,
which is a deviation from the expected twofold increase
due to these cells having two additional copies of the gene
(Figure 4b, bottom panel, Additional file 7: Figure S5B).
UBE3A is imprinted in iPSC-derived neurons and, ac-
cordingly, UBE3A expression levels were less than 25%
of normal levels in AS iPSC-derived neurons. In idic
(15) iPSC-derived neurons, UBE3A levels were about
2.5-fold higher than normal neurons, as expected for
cells with three active copies of the gene (Figure 4b,
bottom panel; Additional file 7: Figure S5B).In the maternal int dup(15) iPSC-derived neurons
(mat. int dup(15)-02), we found that UBE3A was
expressed at the predicted 1.5-fold over normal. How-
ever, UBE3A was also increased to a similar degree in
the isogenic normal (mat. int dup(15)-12) neurons. In
order to understand this apparent discrepancy in ex-
pected UBE3A expression, we analyzed UBE3A copy
number in the maternal int dup(15) and isogenic nor-
mal clones using a qPCR CNV assay, and determined
that both cell lines had three copies of UBE3A [see
Additional file 8: Figure S6A]. In addition, we detected
RNA expression from three UBE3A alleles by RNA-
FISH with a UBE3A BAC probe in iPSCs of both cell
lines [see Additional file 8: Figure S6B]. This suggests
that while initial analysis of iPSC clones, using DNA
FISH for SNRPN and the PWS-IC methylation assay,
indicated that the mat. int dup(15)-12 clone did not
contain the 15q11-q13.1 duplication, this clone was
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solved to consist mostly of duplication-carrying cells.
Therefore, we can interpret data generated using this
cell line as a second maternal interstitial duplication
clone.
15q11-q13.1 gene expression in the maternal int dup
(15) and paternal int dup(15) iPSC-derived neurons did
not correlate well with expressed copy number for several
genes (Figure 4a, bottom panel). HERC2 levels were three-
fold higher than normal in maternal int dup(15) neurons,
as opposed to the predicted 1.5-fold increase from the
three expressed copies of the gene in these cells (Figure 4b,
bottom panel). We also observed unexpected increases in
expression of CYFIP1 and CHRNA7 in both the maternal
and paternal int dup(15) iPSC-derived neurons (Figure 4b,
bottom panel). We did observe the expected increase
in SNRPN expression in the paternal int dup(15) neu-
rons, however, expression of NIPA1, UBE3A, HERC2,
and CHRNA7 were also higher than expected based on
expressed copy number.
Together, these data suggest that gene expression level
correlates well with expressed copy number in iPSCs but
less so in iPSC-derived neurons (compare top and
bottom panels of Figure 4a). Furthermore, interstitial
duplication iPSCs and neurons are more likely to have
gene expression levels different from expected levels based
on expressed copy number.
Transcriptome analysis of AS, normal, and idic(15)
iPSC-derived neurons
We also sought to analyze gene expression genome-
wide. To test the hypothesis that alterations in gene ex-
pression would reflect either 1) disrupted pathways caused
by altered dosage of the duplicated 15q region or 2) the
transcriptional responses to the physiological changes in
the AS and idic(15) neurons, we performed strand-specific
mRNA-Seq on 10-week old neurons generated from AS,
normal, and idic(15) (Idic1-8) iPSCs. mRNA-Seq data
were generated using neurons derived from two inde-
pendent rounds of in vitro differentiation using the EB
protocol from iPSCs of each of the three genotypes.
Gene expression levels were compared between bio-
logical replicates and were found to be highly similar
[see Additional file 9: Table S3, r2 ≥ 0.97]. The gene
expression levels for the replicates were averaged and
the AS and idic(15) samples were each compared to the
normal sample.
Genes showing a twofold increase or decrease in expres-
sion compared to the normal sample were considered
differentially expressed between those two samples. 5,369
genes were differentially expressed between idic(15) and
normal iPSC-derived neurons (Figure 5a). A total of 1,667
genes were found to be differentially expressed between
AS and normal iPSC-derived neurons (Figure 5a). Ofthese, 751 genes were differentially expressed in both sam-
ples compared to normal (Figure 5a). The number of
genes found to be differentially expressed in both samples
is greater than expected by chance (hypergeometric distri-
bution with population size = 27,297; P = 1.88 X 10−131).
Moreover, 76% of the genes differentially expressed
in both AS and idic15 neurons show the same ten-
dency (that is, both upregulated or both downregulated).
Figure 5b shows a heat map of the top 200 most differen-
tially expressed genes in both samples. Gene Ontology
analysis was performed on the lists of genes specifically
up- or downregulated in AS and idic(15) neurons com-
pared to normal neurons [see Additional file 10: Table S4,
Additional file 11: Table S5, Additional file 12: Table S6,
and Additional file 13: Table S7]. The gene ontology term
‘neuronal differentiation’ was the most significantly
enriched category from the lists of genes downregulated
in both AS and idic(15) neurons (P = 9.7 X 10−10 and
P = 4.31 X 10−8 for AS and idic(15) neurons, respect-
ively). Genes involved in cell cycle (P = 1.64 X 10−23)
and protein catabolic processes (P = 5.96 X 10−19) were
enriched among the list of genes upregulated in idic(15)
neurons.
Interestingly, several known autism and epilepsy can-
didate genes, namely distal-less homebox 2 (DLX2),
aristaless related homeobox (ARX), ISL LIM homeobox
1 (ISL1), neuroligin 1 (NLGN1), SH3 and multiple ankyrin
repeat domains 1 (SHANK1), adenosine A2A receptor
(ADORA2A), and distal-less homeobox 5 (DLX5), were
found in the list of genes differentially expressed and
downregulated in AS or idic(15). To validate the tran-
scriptome data and further interrogate some of these
genes, qRT-PCR was performed on RNAs isolated from
normal, AS and idic(15) (Idic1-8) neurons (Figure 6a).
All seven of the genes assayed were shown to be downreg-
ulated in both AS and idic(15) iPSC-derived neurons. qRT-
PCR data from 19 different genes demonstrated agreement
between qRT-PCR and mRNA-Seq data (Figure 6b). Al-
though maternal int dup(15) iPSC-derived neurons were
not included in the whole transcriptome analysis, we also
assayed expression of the selected autism and epilepsy
candidate genes in these neurons by qRT-PCR. We ob-
served that, with the exception of ADORA2A, expression
of these genes was also downregulated in maternal int dup
(15) iPSC-derived neurons when compared to normal
neurons [see Additional file 14: Figure S7].
Rescue of normal UBE3A expression levels in idic(15)
iPSC-derived neurons
To investigate whether the aberrant expression levels
of UBE3A in idic(15) neurons could be pharmacologic-
ally manipulated, we treated 10-week-old idic(15) iPSC-
derived monolayer neuron cultures with the DNA-binding
compound mithramycin. This drug binds to GC-rich
Figure 5 Most of the genes differentially expressed in both Angelman syndrome (AS) and isodicentric chromosome 15 (idic(15))
induced pluripotent stem cell (iPSC)-derived neurons compared to normal are changed in the same direction. (a) Venn diagram
depicting the number of genes differentially expressed (twofold up or down) between AS (AS del 1-0) and idic(15) (Idic1-8) iPSC-derived neurons
compared to normal (Nml 1-0) iPSC-derived neurons. The overlap of the two circles represents the set of shared differentially expressed genes in
both AS and idic(15). (b) Heat map showing the mRNA expression levels relative to normal (Nml 1-0) of the top 200 genes differentially expressed
in both AS (AS del 1-0) and idic(15)(Idic1-8) iPSC-derived neurons. Genes are clustered according to their similarity in gene expression levels across
both samples. Genes colored in yellow show expression levels greater than normal, and genes colored in blue show expression levels less than
normal. The trace lines indicate the expression levels of individual genes relative to normal. Normal expression level is indicated by the straight
dotted lines.
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transcription factors that regulate gene expression [36,37].
We reasoned that since the UBE3A promoter is GC-rich
and is known to be occupied by many transcription factors
in various cell types [38], competition for binding by
mithramycin may alter the levels of UBE3A transcription.
Following 72 hours of drug treatment, we found that
UBE3A mRNA levels in idic(15) neurons were reduced in
a dose-dependent manner to levels near that of normaliPSC-derived neurons (Figure 7a). These data suggest that
UBE3A can be pharmacologically regulated at the tran-
scriptional level by mithramycin. However, competition
for transcription factor binding by mithramycin is not spe-
cific for UBE3A and occurs at many gene promoters. In
line with this, we detected changes in expression levels of
several other genes following mithramycin treatment, in-
cluding the other 15q11-q13.1 genes SNRPN, GABRB3,
and CYFIP1 [see Additional file 15: Figure S8].
Figure 6 Quantitative reverse transcription PCR (qRT-PCR) validation of mRNA-Seq data. (a) Differential gene expression of select autism
candidate genes and genes implicated in seizure disorders were verified by qRT-PCR in 10-week-old AS (AS del 1-0), normal (Nml 1-0), and
idic(15) (Idic1-8) iPSC-derived neurons. P values: *P ≤0.1, **P ≤0.05, ***P ≤0.01. (b) Correlation of relative expression levels for 19 genes in
iPSC-derived neurons as determined by mRNA-Seq and qRT-PCR. The log2-transformed RQ values for mRNA expression relative to normal neurons
are plotted on the x-axis against the log2-transformed FPKM values obtained by mRNA-Seq analysis (y-axis).
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mithramycin treatment rescues UBE3A expression levels,
we assayed transcription factor binding to UBE3A by
ChIP. It is well established that mithramycin inhibits
binding of the Sp1 transcription factor and affects tran-
scription of Sp1 target genes [37,39]. We were unable to
detect Sp1 enrichment at several sites analyzed within
the UBE3A promoter [see Additional file 16: Figure S9A].
For this reason, we instead analyzed binding of the tran-
scription factor yin yang 1 (YY-1), which we confirmedFigure 7 Rescue of normal UBE3A expression levels following treatme
stem cell (iPSC)-derived neurons with mithramycin. (a) qRT-PCR analys
iPSC-derived neurons following 72 hours of treatment with DMSO (vehicle)
are presented as mean expression levels relative to that of untreated norm
binding at two sites in UBE3A, one within exon 1 and one upstream of exo
72 hours of treatment with either DMSO or 100 nM mithramycin.does bind within the UBE3A promoter in both iPSCs and
iPSC-derived neurons [see Additional file 16: Figure S9B].
YY-1 can act both as a transcriptional activator and re-
pressor [40]. Transcriptional repression by YY-1 is thought
to be mediated by recruitment of histone deacetylases and
histone acetyltransferases [41]. We assayed binding of
YY-1 to UBE3A at two sites, one within exon 1 and one
about 250 base pairs upstream of exon 1, following
treatment of idic(15) iPSC-derived neurons for 72 hours
with either 100 nM mithramycin or DMSO. While therent of isodicentric chromosome 15 (idic(15)) induced pluripotent
is of UBE3A mRNA expression in 10-week-old idic(15) (Idic1-8)
or mithramycin at concentrations ranging from 25 nM to 1 μM. Data
al (Nml 1-0) iPSC-derived neurons. (b) ChIP-qPCR analysis of YY-1
n 1, in 10-week-old idic(15) (Idic1-8) iPSC-derived neurons following
Germain et al. Molecular Autism 2014, 5:44 Page 14 of 19
http://www.molecularautism.com/content/5/1/44was no significant difference between the treatments in
binding of YY-1 at exon 1, binding at the upstream site was
increased in mithramycin-treated neurons to roughly 1.4-
fold that of DMSO-treated neurons (Figure 7b, P = 0.0571).
These data suggest that mithramycin treatment may recruit
YY-1 to the UBE3A promoter, where it can act in a repres-
sive manner to decrease UBE3A expression levels.
Discussion
Dup15q syndrome is a genetic form of autism in which
the features of affected individuals closely resemble
those in idiopathic autism [1,2,8,9]. In addition to the
impairments in social interaction, verbal and nonverbal
communication, and stereotyped behavior that underlie
autism, individuals with Dup15q syndrome also suffer
from hypotonia, seizures, developmental delay, and be-
havioral problems. We have generated iPSC models of
Dup15q syndrome from a variety of patient samples
containing different CNVs of the 15q11-q13.1 region.
We show that the imprinting status of the PWS-IC is
maintained following reprogramming of patient samples
and that the ratio of methylated to unmethylated DNA
at the PWS-IC confirms the expected 15q11-q13.1 copy
number in each patient-derived iPSC line. Importantly,
we demonstrated that all of the iPSC lines we generated
can be differentiated into functionally mature neurons,
as indicated by immunocytochemistry and electrophysi-
ology. The ability to generate functional human neurons
in large numbers from these iPSCs will enable us to per-
form molecular and cellular phenotypic analyses, and to
test candidate therapeutic compounds in live human
Dup15q neurons. Thus, these cell lines are an important
resource for understanding Dup15q syndrome as well as
idiopathic autism.
In contrast to AS, a single gene disorder which can re-
sult from loss of function of the UBE3A gene alone, it is
not known whether Dup15q syndrome results from over-
expression of UBE3A or from overexpression of UBE3A
plus one or more other genes in the 15q11-q13.1 region.
Since maternal, but not paternal duplications typically lead
to the Dup15q syndrome, a role for UBE3A seems highly
likely. However, the contribution of other genes has been
difficult to explore since the only patient specimens
available were blood or post-mortem tissues that may
not accurately reflect the gene expression observed in
live neurons. Our iPSC models of Dup15q allow for
gene expression analysis in live human neurons carry-
ing the various 15q11-q13.1 CNVs. This experimental
system also permits us to better resolve some of the
confounding issues involved with post-mortem brain
samples (variable mRNA or protein quality) and with
genetically engineered transformed cell lines (unknown
genetic and epigenetic aberrations) that have been pre-
viously used to study Dup15q syndrome [34,42].Our analysis of 15q11-q13.1 gene expression in undif-
ferentiated iPSCs showed that, on the whole, expression
levels in all genotypes correlated with 15q11-q13.1 copy
number, including proper allele-specific expression of
imprinted SNRPN. Consistent with previous findings
in patient lymphoblasts [35], fibroblasts [43], and post-
mortem brain [34], we confirmed increased expression
of UBE3A in iPSCs derived from two separate idic(15)
individuals. We also observed increased expression of
several other genes included in the duplication region
such as CYFIP1, GABRB3, and HERC2.
We found that following differentiation of iPSCs into
functionally mature neurons, 15q11-q13.1 transcript levels
did not consistently correlate with copy number. For ex-
ample, CYFIP1 expression was increased relative to nor-
mal in both maternal and paternal int dup(15) neurons,
which do not have a duplication of CYFIP1. Meanwhile,
TUBGCP5 levels were significantly reduced in maternal
int dup(15) neurons. In addition, a striking threefold
increase in non-imprinted HERC2 expression was ob-
served in maternal int dup(15) neurons, while the pre-
dicted expression level was 1.5-fold of normal. Interestingly,
we also observed slight increases in expression of CHRNA7,
a gene located well outside of the duplication region in
both maternal and paternal int dup(15) neurons. AS
iPSC-derived neurons, in which CHRNA7 copy number
is unaffected, also showed a significant twofold increase
of CHRNA7 compared to normal neurons. Together,
these data suggest that, in neurons, transcription of
genes both within and adjacent to the 15q11-q13.1 du-
plication region is not correlated to gene copy number.
There are at least three possible reasons for these unex-
pected gene expression changes: 1) individual-to-individual
variability; 2) disruption of long-distance regulatory el-
ements by the chromosomal duplications; or 3) aber-
rant function of the neurons not associated with the
chromosomal rearrangement.
Normal individual-to-individual variability is a con-
founding problem for gene expression studies in any
human tissue type or patient-derived cell line. In some
cases, the variability between individuals can be signifi-
cant due to the different genetic backgrounds. We can-
not rule out the possibility that the unexpected gene
expression changes that we observe are due to normal
variation. This appears unlikely, however, since the gene
expression in the Dup15q iPSCs very closely reflects the
copy number of the interrogated genes. The problems
associated with normal variation can be addressed by
examining samples from multiple individuals or by com-
paring isogenic Dup15q and normal cell lines. We have
compared gene expression in iPSC-derived neurons from
two different idic(15) individuals, and they show similar
expression levels of all genes, except for ATP10A and
HERC2. ATP10A is highly variable between replicate
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cult to analyze even in mouse models where the genetic
background is the same [44]; thus, changes in its ex-
pression levels are difficult to interpret. HERC2 encodes
a ubiquitin ligase that has been shown to act in a complex
with UBE3A [45]. The increased HERC2 levels could con-
ceivably influence the severity of the symptoms in some
idic(15) individuals. Isogenic cell lines can be obtained by
deriving Dup15q and normal cell lines from the same mo-
saic individual, as attempted for our maternal intersti-
tial duplication individual, or by genetically correcting
the duplication in individual cell lines. These comparisons
will be important future studies for Dup15q syndrome.
Our results indicate that the correlation between gene
expression level and copy number is different in intersti-
tial versus isodicentric 15q11-13.1 duplications, and we
suspect that alterations in long range chromatin regulation
may be involved. Several models have been proposed to
explain how deletions and duplications of genes or large
regions of DNA can alter transcription of a given gene. In
particular, regulatory sequences can be disrupted by direct
mutation of promoters and enhancers. Alternately, bind-
ing sites for proteins that mediate the necessary chromatin
looping required for proper gene expression can be
disrupted. Abrogation of long-distance transcriptional
regulation due to chromosomal rearrangements has
been implicated in several human diseases [46], and our
data may suggest such a mechanism in Dup15q syndrome.
We hypothesize that chromatin-organizing regulatory ele-
ments exist near the duplication/deletion breakpoints. The
function of these regulatory elements may be disrupted by
the duplication or deletion events. The effect of this regu-
latory disruption is predicted to affect interstitial duplica-
tions and deletions more than idic(15) samples, consistent
with our results.
It is possible, however, in neurons that undergo silen-
cing of the paternal UBE3A allele and complex changes
in chromatin structure that transcription from the extra
maternal UBE3A alleles is subject to differential regula-
tion [47]. Studies using an engineered neuroblastoma
cell line model of Dup15q showed aberrant expression
levels of several 15q11-q13.1 genes compared to levels
predicted by copy number [42]. Meguro-Horike et al.
propose that the discordance in transcript levels com-
pared to copy number of 15q11-q13.1 genes is a result
of a disruption of transcriptional regulation normally
mediated either by pairing of homologous chromosomes
or by intra-chromosomal pairing in cells containing
extra 15q11-q13.1 alleles [42].
We also investigated genome-wide gene expression
differences between idic(15), AS, and normal iPSC-derived
neurons. Altered UBE3A gene dosage is proposed to under-
lie most of the phenotypic consequences of Dup15q syn-
drome [4,8,14]. We reasoned that gene expression changesthat are caused by increases in UBE3A expression in
Dup15q neurons should be reversed in AS neurons that
have decreased UBE3A expression. In addition to its
role in ubiquitination, UBE3A acts as a transcriptional
co-activator. UBE3A can also affect gene transcription
via ubiquitination of protein targets in signaling path-
ways or by directly changing expression levels of indi-
vidual genes. In both cases, the UBE3A-mediated effects
on transcription should be opposite between idic(15)
and AS neurons. As expected, there were more changes
between idic(15) and normal than AS and normal neu-
rons. This is likely due to the fact that the idic(15) neurons
have two extra copies of a 9.6 Mb region, while AS
neurons have one less copy of a 5.1 Mb region.
When considering the genes differentially expressed in
both AS and idic(15) neurons compared to normal neu-
rons, we found more similarities than differences. A re-
markable 75% of all genes found differentially expressed
and common to both idic(15) and AS neuron samples
showed a similar expression pattern (that is, both down-
regulated or both upregulated), contrary to our hypothesis
that AS and idic(15) are ‘opposite’ disorders. In fact, the
same gene ontology term was identified amongst genes
downregulated in both AS and idic(15) neurons. Since
these gene expression changes represent changes at the
mRNA level and not necessarily the protein level, we
speculate that the shared changes result from a common
neuronal response to malfunctioning synapses. We sus-
pect that these gene expression changes are secondary to
the chromosomal duplication or deletion, and may even
occur in neurodevelopmental disorders not involving the
chromosome 15q11-q13.1 region. Consistent with this
idea, the M12 gene module identified by Voineagu et al.
[48], that is transcriptionally downregulated in postmor-
tem brain samples from idiopathic autism cases shares
similar gene ontology terms to those downregulated in
idic(15) and AS neurons, including terms involving synap-
ses, axons, and neuron projections.
The major categories of genes upregulated in idic(15)
neurons include genes involved in the cell cycle and
those involved in protein catabolism, including those in-
volved in ubiquitin-mediated proteolysis. Why the cell
cycle would be affected in postmitotic neurons is perplex-
ing. Growing evidence suggests that abnormal expression
of cell cycle genes can participate in neuronal death, but
neither increased nor decreased neuronal death has been
observed in Dup15q syndrome or in our cell culture
models. A recent report showed that the retinoblastoma 1
(RB1) protein is required for continuous cell cycle repres-
sion and neuronal survival [49], and it is becoming more
apparent that post-mitotic neurons actively repress the cell
cycle [50]. It is possible that the upregulated cell cycle genes
serve to repress the cell cycle and may represent more
rapid maturation of the idic(15) in vitro differentiated
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genes. There are also several proteasome subunit and
ubiquitin-mediated proteolysis genes that are included
among the cell cycle genes, thereby contributing to the
significance of this gene ontology term. The upregulation
of genes involved in protein catabolism and ubiquitin me-
diated proteolysis is somewhat expected, although it is in-
teresting that a large number of genes involved in this
pathway are upregulated. Ube3a was recently shown to
regulate protein homeostasis by directly ubiquitinating
Rpn10, a proteasomal shuttling protein, in Drosophila
melanogaster [51]. If Rpn10 is shown to be a target of
UBE3A in human neurons, this could explain the dysregu-
lation of protein catabolism in idic(15) neurons.
We sought to reduce UBE3A mRNA levels in idic(15)
neurons. Using our iPSC model of idic(15), we were able
to perform a proof-of-principle experiment to deter-
mine whether UBE3A levels could be pharmacologically
reduced in human neurons. We found that treatment of
idic(15) iPSC-derived neurons with the DNA binding
compound mithramycin, an anti-tumor antibiotic, was
able to reduce UBE3A mRNA to levels similar to that
of normal neurons. While several studies have shown
that mithramycin inhibits transcription by competing
for binding at GC-rich regions with the transcription
factor Sp1 [37,39], we were unable to demonstrate Sp1
binding at UBE3A by ChIP in our neurons after trying
three different anti-Sp1 antibodies. We did, however,
make the novel observation that binding of YY-1 is in-
creased following mithramycin treatment. Since YY-1
can act as both a transcriptional activator and repressor
[40], we hypothesize that YY-1 acts in a repressive manner
at UBE3A as increased binding is associated with a reduc-
tion in UBE3A transcript following mithramycin treat-
ment. YY-1 mediated transcriptional repression has been
shown to involve recruitment of histone deacetylases and
histone acetyltransferases and thereby establishment of re-
pressive chromatin modifications [41]. While mithramycin
is an FDA-approved drug used in the treatment of various
cancers [52-54], we do not suggest that it is suitable for
use in the clinical treatment of Dup15q, due to its effects
on the expression of many other genes. Our findings do
demonstrate the feasibility of using Dup15q iPSC-derived
neurons to screen for other therapeutic compounds with
the aim of restoring normal UBE3A expression levels.
Conclusions
We have derived iPSC lines from two idic(15) individuals,
one maternal int dup(15) individual and one paternal int
dup(15) individual. These iPSCs can be differentiated into
electrophysiologically mature neurons. These cell lines are
an important resource for studies of Dup15q syndrome
and idiopathic autism. Our analysis of gene expression in
iPSCs and iPSC-derived neuronal cultures containingvaried CNVs of the 15q11-q13.1 region supports the the-
ory that altered expression of several genes in this region
may underlie the Dup15q phenotype. While altered
UBE3A gene dosage is often proposed to be the mechanism
responsible for Dup15q syndrome, our data along with data
from other studies [8,34,42] suggest that disruption of add-
itional candidate genes may contribute significantly. Altered
expression of such additional genes may be due to either
their presence in the duplication region or to disruption of
their transcriptional regulation as a result of the chromo-
somal rearrangement (and thus independent of copy num-
ber). As a result, our data also point to possible disruption
of transcriptional regulation of genes in the duplication re-
gion in iPSC-derived neurons. Finally, we restored UBE3A
mRNA levels in idic(15) neurons to normal levels using the
antitumor antibiotic, mithramycin, demonstrating that
UBE3A mRNA levels could be manipulated pharmaco-
logically. Future studies in which the expression levels of in-
dividual genes are reduced or that compare Dup15q
neurons with isogenic control neurons may help delineate
the precise roles of individual genes in this disorder.
Availability of supporting data
The data set supporting the results of this article is
available in the National Center for Biotechnology In-
formation (NCBI) Sequence Read Archive (SRA), under
the accession number SRP044749 (http://www.ncbi.nlm.
nih.gov/sra/?term=srp044749).
Additional files
Additional file 1: Table S1. List of induced pluripotent stem cell (iPSC)
lines used in this study, parental tissue source, and method of
reprogramming used. iPSCs were generated from an Angelman
syndrome (AS) individual (AS del 1–0), a normal individual (Nml 1–0), an
individual with an interstitial duplication of the maternal 15q11-q13.1
allele (mat. int dup(15)-12 and mat. int dup(15)-02), an individual with an
interstitial duplication of the paternal 15q11-q13.1 allele (pat. int dup(15)-04),
and two individuals with an isodicentric chromosome 15 of maternal
origin (Idic1-8 and IdicCB-09). The copy number of maternal or paternal
15q11-q13.1 in each cell line, the parental somatic cell source, and the
reprogramming method used are indicated.
Additional file 2: Figure S1. Characterization of pluripotency of
Dup15q induced pluripotent stem cells (iPSCs). (A) Quantitative reverse
transcription PCR (qRT-PCR) analysis for selected pluripotency genes
using a TaqMan human pluripotency gene array with representative iPSC
clones of each Dup15q genotype. H9 hESCs and iPSCs from a normal
individual (Nml 1–0) are included as reference samples. (B) qRT-PCR
analysis of day 16 embryoid bodies derived from representative clones of
each Dup15q genotype using a TaqMan human pluripotency array.
Additional file 3: Table S2. Methylation analysis of Dup15q induced
pluripotent stem cells (iPSCs) at the Prader-Willi syndrome imprinting
center (PWS-IC) (individual iPSC clones). DNA methylation at the PWS-IC
was assayed by methylation specific quantitative PCR (qPCR) using
genomic DNA from Dup15q iPSCs. The calculated percent methylation
for each clone within a genotype is presented from one assay per clone.
*The mat. int dup(15)-12 clone, while originally identified as having a
normal methylation status of 54%, subsequently demonstrated the 66%
methylation status indicative of the maternal interstitial duplication
containing clones, suggesting that this clone was mosaic for the
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http://www.molecularautism.com/content/5/1/44duplication. ** The mat. int dup(15)-18 clone was also shown to be a
mixed clone by DNA fluorescence in situ hybridization (FISH) analysis
using a probe for SNRPN.
Additional file 4: Figure S2. Allele-specific reverse transcription PCR
(RT-PCR) for paternally expressed imprinted in Prader-Willi syndrome
(IPW) in patient fibroblasts, induced pluripotent stem cells (iPSCs), and
iPSC-derived neurons. DNA sequencing of genomic DNA from either
patient fibroblasts (mat. int dup(15), pat. int dup(15), and idic(15)) or iPSCs
(idic(15) cord blood (IdicCB-09)) indicates the presence of a polymorphic
single nucleotide polymorphism (SNP), rs691, in the last exon of the
imprinted in Prader-Willi syndrome (IPW) gene (arrows). Sequencing of
cDNA derived from patient fibroblasts, iPSCs, and 10-week-old
iPSC-derived neurons demonstrates that expression of IPW in all samples
is monoallelic. Expression of the same allele (as indicated by DNA
sequencing traces containing the same nucleotide at rs691, (asterisks)) in
fibroblasts, iPSCs, and iPSC-derived neurons suggests that the parental
imprinting of IPW is maintained following reprogramming and
differentiation of iPSCs into neural derivatives. We were unable to analyze
cDNA from pat. int dup(15) fibroblasts and idic(15) cord blood due to a
lack of sufficient patient cells for generating RNA.
Additional file 5: Figure S3. Analysis of neural differentiation of
Dup15q induced pluripotent stem cell (iPSC) clones using a custom
neural differentiation quantitative PCR (qPCR) array. Each iPSC clone
derived from Dup15q patient samples was assayed for neural
differentiation capacity using a custom TaqMan neural differentiation
qPCR array. iPSCs derived from individuals with a maternal interstitial
duplication (A), paternal interstitial duplication (B), or idic(15) (fibroblast
sample, C, and umbilical cord blood, D) were spontaneously
differentiated via embryoid body formation for 16 days. Neural gene
expression levels were analyzed relative to expression in AS del 1–0 day
16 embryoid bodies. AS del 1–0 is used as a calibrator sample since it has
previously been published to readily generate mature neurons and
astrocytes [18]. Embryoid bodies derived from H9 hESCs and normal
iPSCs (Nml 1–0) were included in analysis for comparison purposes. The
pluripotency genes NANOG and ZFP42 were also included in analysis to
assay downregulation of pluripotency genes during differentiation.
Additional file 6: Figure S4. Characterization of Dup15q induced
pluripotent stem cell (iPSC)-derived neural cultures. (A) Triplicate
independently-derived 10-week-old neural cultures from each Dup15q
cell line were analyzed by qRT-PCR for markers of neurons and glia
(βIII-tubulin, RBFOX3, TBR1, and S100β) excitatory and inhibitory neurons
(VGLUT2 and GAD1), and forebrain and midbrain neurons (FOXG1, PAX6,
OTX2, and EN1). Data are presented as mean expression relative to
GAPDH. (B) Mean expression levels of each gene were compared
between cell lines using one-way ANOVA followed by Tukey’s multiple
comparison post hoc test. Pairwise comparisons having significant
P values (P <0.05) for each gene are listed.
Additional file 7: Figure S5. Expression of 15q11-q13.1 genes in
Dup15q induced pluripotent stem cell (iPSCs) and iPSC-derived neurons.
(A) qRT-PCR analysis of selected 15q11-q13.1 genes in iPSCs. iPSC lines
are presented from left to right in order of increasing 15q11-q13.1 copy
number. Genes are arranged along the x-axis in the order of their
location within the 15q11-q13.1 region. (B) qRT-PCR analysis of selected
15q11-q13.1 genes in 10-week-old iPSC-derived neurons.
Additional file 8: Figure S6. Analysis of UBE3A copy number in
induced pluripotent stem cell (iPSCs). (A) The genomic copy number of
UBE3A was analyzed by qPCR in each iPSC line using TaqMan Copy Number
Assays. UBE3A copy number was calculated using RNase P as an endogenous
reference. Error bars indicate standard error of the mean. (B) RNA FISH for
UBE3A in iPSCs shows RNA expression from two (Nml 1–0), three (mat. int
dup(15)-02 and mat. int dup(15)-12) or four (Idic1-8) UBE3A alleles. Arrows
indicate positive FISH signal. Nuclei are labeled with DAPI (blue).
Additional file 9: Table S3. mRNA-Seq data from AS (AS del1-0),
normal (Nml 1-0), and idic(15) (Idic1-8) induced pluripotent stem cell
(iPSC)-derived neurons. The tab titled “transcriptome data in neurons”
shows the averaged fragments per kilobase pair per million mapped
reads (FPKM) values for mRNA-Seq performed on two biological
replicates of AS del1-0, Nml1-0, and Idic1-8 iPSC-derived neurons. The “ASvs. Normal” tab shows a scatter plot comparing the Log2 transformed
FPKM+1 values for AS del1-0 and Nml1-0 iPSC-derived neurons. The
“Idic(15) vs. AS” tab shows a scatter plot comparing the Log2 transformed
FPKM+1 values for Idic1-8 and AS del1-0 iPSC-derived neurons. The “Idic
(15) vs. Normal” tab shows a scatter plot comparing the Log2 transformed
FPKM+1 values for Idic1-8 and Nml1-0 iPSC-derived neurons. The “Idic(15)
vs. Idic(15)” tab shows a scatter plot comparing the Log2 transformed
FPKM+1 values for the two biological replicates of Idic1-8 iPSC-derived
neurons.
Additional file 10: Table S4. Gene Ontology analysis of genes
upregulated in idic(15) (Idic1-8) induced pluripotent stem cell (iPSC)-derived
neurons. Genes upregulated in idic(15) iPSC-derived neurons at least
twofold compared to normal were subject to analysis using DAVID
(http://david.abcc.ncifcrf.gov). Gene ontology terms representing the
function of the genes upregulated are shown along with the
corresponding statistical analysis.
Additional file 11: Table S5. Gene Ontology analysis of genes
upregulated in AS del 1–0 induced pluripotent stem cell (iPSC)-derived
neurons. Genes upregulated in AS iPSC-derived neurons at least twofold
compared to normal were subject to analysis using DAVID (http://david.abcc.
ncifcrf.gov). Gene ontology terms representing the function of the genes
upregulated are shown along with the corresponding statistical analysis.
Additional file 12: Table S6. Gene Ontology analysis of genes
downregulated in idic(15) (Idic1-8) induced pluripotent stem cell
(iPSC)-derived neurons. Genes downregulated in idic(15) iPSC-derived
neurons at least twofold compared to normal were subject to analysis
using DAVID (http://david.abcc.ncifcrf.gov). Gene ontology terms
representing the function of the genes downregulated are shown along
with the corresponding statistical analysis.
Additional file 13: Table S7. Gene Ontology analysis of genes
downregulated in AS del 1–0 induced pluripotent stem cell
(iPSC)-derived neurons. Genes downregulated in AS iPSC-derived neurons
at least twofold compared to normal were subject to analysis using
DAVID (http://david.abcc.ncifcrf.gov). Gene ontology terms representing
the function of the genes downregulated are shown along with the
corresponding statistical analysis.
Additional file 14: Figure S7. Analysis of autism candidate genes in
maternal int dup(15) induced pluripotent stem cell (iPSC)-derived neurons.
Differential gene expression of select autism candidate genes and genes
implicated in seizure disorders were analyzed by qRT-PCR in 10-week-old
normal (Nml 1–0), maternal int dup(15) (mat int dup(15)-02), and idic(15)
(Idic1-8) iPSC-derived neurons. P values: *P ≤0.1, **P ≤0.05, ***P ≤0.01.
Additional file 15: Figure S8. Off-target effects of mithramycin
treatment in idic(15) induced pluripotent stem cell (iPSC)-derived neurons.
qRT-PCR analysis of SNRPN, GABRB3, and CYFIP1 expression in 10-week-old
idic(15) (Idic1-8) iPSC-derived neurons following 72 hours of treatment with
mithramycin or DMSO. P values: *P ≤0.1, **P ≤0.05, ***P ≤0.01.
Additional file 16: Figure S9. Chromatin immunoprecipitation (ChIP)
analysis of Sp1 and YY-1 binding at the UBE3A promoter. (A) ChIP-qPCR
assays were performed on idic(15) (Idic1-8) iPSC-derived neurons using
two different antibodies against Sp1. With anti-Sp1 antibody #1 (Santa
Cruz Biotechnology, Inc.), we were unable to detect significant
enrichment over background signal (IgG) suggesting that this antibody
does not work in our hands. Using anti-Sp1 antibody #2 (Cell Signaling
Technologies), we detected low levels of enrichment at two sites at
UBE3A (one within exon 1 and one upstream of exon 1), however, when
compared to enrichment at the Sp1 promoter and the DHFR promoter –
two positive control locations, we concluded that binding of Sp1 to
UBE3A is not significant. (B) ChIP-qPCR assays were performed on idic(15)
(Idic1-8) iPSC-derived neurons to analyze binding of YY-1 to two locations
at UBE3A, one within exon 1 and one upstream of exon 1. Data are
presented as the mean enrichment from triplicate ChIP experiments plus
or minus the standard error of the mean.Abbreviations
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